(Q36677261)

15 August 2017

1 reference

title

Biomarkers for the development of cancer vaccines: current status (English)

1 reference

15 August 2017

0 references

3

Angus Dalgleish

1 reference

15 August 2017

John Copier

1

1 reference

PubMed ID

17154650

15 August 2017

Mike Whelan

series ordinal

2

1 reference

15 August 2017

1 January 2006

1 reference

Molecular Diagnosis and Therapy

15 August 2017

1 reference

15 August 2017

10

1 reference

15 August 2017

6

1 reference

15 August 2017

337-343

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03256210

15 August 2017

0 references

cites work

Significance of serum amyloid A on the prognosis in patients with renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Protein chip array profiling analysis of sera from neuroblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Delayed disease progression after allogeneic cell vaccination in hormone-resistant prostate cancer and correlation with immunologic variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Processing and presentation of tumor antigens and vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Update on cancer vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

DNA vaccination against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Dendritic cells as therapeutic vaccines against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Tracking T cells with tetramers: new tales from new tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Multiplexed particle-based flow cytometric assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Cytometric bead array: a multiplexed assay platform with applications in various areas of biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Epitope spreading in immune-mediated diseases: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Pretreatment serum interleukin-6 concentration as a prognostic factor of overall survival in metastatic malignant melanoma patients treated with biochemotherapy: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Prognostic significance of autoimmunity during treatment of melanoma with interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Prostate-specific antigen in prostate cancer: a case study in the development of a tumor marker to monitor recurrence and assess response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Gene expression profiling: from microarrays to medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Common markers of proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Advancing cancer biotherapy with proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Immunomonitoring Tumor-Specific T Cells in Delayed-Type Hypersensitivity Skin Biopsies After Dendritic Cell Vaccination Correlates With Clinical Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256210

Surveillance programs for early stage non-seminomatous testicular cancer: a practice guideline.

21 January 2018

1 reference

12 December 2020

Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation

1 reference

12 December 2020

Anticancer vaccination strategies

1 reference

12 December 2020

Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.

1 reference

12 December 2020

Artificial neural network technologies to identify biomarkers for therapeutic intervention.

1 reference

12 December 2020

Screening for ovarian cancer

1 reference

12 December 2020

New methods for assessing T-cell responses

1 reference

12 December 2020

Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients

1 reference

12 December 2020

Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome

1 reference

12 December 2020

Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma

1 reference

12 December 2020

Serum interleukin 6 as a prognostic factor in patients with prostate cancer

1 reference

12 December 2020

Injury to research volunteers--the clinical-research nightmare

1 reference

12 December 2020

Prognostic and predictive molecular markers in colorectal carcinoma.

1 reference

12 December 2020

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

1 reference

12 December 2020

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

1 reference

12 December 2020

Circulating interleukin-6 predicts survival in patients with metastatic breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256210

1 reference

15 August 2017

1 reference

PubMed ID

17154650